A Study of TL-925 as a Treatment for Dry Eye Disease
Clinical trial NCT05745064 · COMPLETED
Trial details
- NCT number
- NCT05745064
- Sponsor
- Telios Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2023-07-11
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.